1,371
Views
60
CrossRef citations to date
0
Altmetric
Guideline and oncology

Prognostic factors for local recurrence and mortality in adult soft tissue sarcoma of the extremities and trunk wall

A cohort study of 922 consecutive patients

, , , , , , & show all
Pages 323-332 | Received 06 Jun 2013, Accepted 10 Feb 2014, Published online: 03 Apr 2014

  • Biau DJ, Ferguson PC, Turcotte RE, Chung P, Isler MH, Riad S, Griffin AM, Catton CN, O’Sullivan B, Wunder JS. Adverse effect of older age on the recurrence of soft tissue sarcoma of the extremities and trunk. J Clin Oncol 2011; 29 (30): 4029-35.
  • Biau DJ, Ferguson PC, Chung P, Griffin AM, Catton CN, O’Sullivan B, Wunder JS. Local recurrence of localized soft tissue sarcoma: A new look at old predictors. Cancer 2012; 118 (23): 5867-77.
  • Cleves M. stata54: Multiple curves plotted with stcurv command. Stata Technical Bull 2000; 9: 7-10.
  • Co-operative Cancer Departments. Treatment of sarcoma and aggressive benign tumors. available at: http://Www.ambkir.dk/Faglige%20retningslinier/Behandling%20af%20sarkomer.pdf. 2007; 2013.
  • Costa J, Wesley RA, Glatstein E, Rosenberg SA. The grading of soft tissue sarcomas. results of a clinicohistopathologic correlation in a series of 163 cases. Cancer 1984; 53 (3): 530-41.
  • Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 1980; (153): 106-20.
  • Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94 (446): 496-509.
  • Fletcher C DM, Unni KK, Mertens F. Pathology and genetics. tumours of soft tissue and bone. ( WHO classification of tumours, volume 5, third edition). IARC Press, Lyon 2002.
  • Graw F, Gerds TA, Schumacher M. On pseudo-values for regression analysis in competing risks models. Lifetime Data Anal 2009; 15 (2): 241-55.
  • Gronchi A, Casali PG, Mariani L, Miceli R, Fiore M, Lo Vullo S, Bertulli R, Collini P, Lozza L, Olmi P, Rosai J. Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: A series of patients treated at a single institution. J Clin Oncol 2005; 23 (1): 96-104.
  • Gustafson P. Soft tissue sarcoma. epidemiology and prognosis in 508 patients. Acta Orthop Scand (Suppl 259) 1994: 1-31.
  • Gutierrez JC, Perez EA, Franceschi D, Moffat FLJr, , Livingstone AS, Koniaris LG. Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry. J Surg Res 2007; 141 (1): 105-14.
  • Jebsen NL, Trovik CS, Bauer HC, Rydholm A, Monge OR, Hall KS, Alvegard T, Bruland OS. Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: A scandinavian sarcoma group study. Int J Radiat Oncol Biol Phys 2008; 71 (4): 1196-203.
  • Jensen OM, Hogh J, Ostgaard SE, Nordentoft AM, Sneppen O. Histopathological grading of soft tissue tumours. prognostic significance in a prospective study of 278 consecutive cases. J Pathol 1991; 163 (1): 19-24.
  • Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 2002; 20 (3): 791-6.
  • Kaytan E, Yaman F, Cosar R, Eralp Y, Saip P, Darendeliler E. Prognostic factors in localized soft-tissue sarcomas. Am J Clin Oncol 2003; 26 (4): 411-5.
  • Koshy M, Rich SE, Mohiuddin MM. Improved survival with radiation therapy in high-grade soft tissue sarcomas of the extremities: A SEER analysis. Int J Radiat Oncol Biol Phys 2010; 77 (1): 203-9.
  • Maguire A, Porta M, Malats N, Gallen M, Pinol JL, Fernandez E. Cancer survival and the duration of symptoms. an analysis of possible forms of the risk function. ISDS II project investigators. Eur J Cancer 1994; 30A (6): 785-92.
  • Maki RG, Moraco N, Antonescu CR, Hameed M, Pinkhasik A, Singer S, Brennan MF. Toward better soft tissue sarcoma staging: Building on American Joint Committee on Cancer Staging systems versions 6 and 7. Ann Surg Oncol 2013; 20 (11): 3377-83.
  • Maretty-Nielsen K, Aggerholm-PedersenNKeller,J, Safwat A, Baerentzen S, Pedersen A. Population-based Aarhus Sarcoma Registry: Validity, completeness of registration, and incidence of bone and soft tissue sarcomas in western Denmark. Clin Epidemiol 2013; 5: 45-56.
  • Nakamura T, Matsumine A, Matsubara T, Asanuma K, Uchida A, Sudo A. The symptom-to-diagnosis delay in soft tissue sarcoma influence the overall survival and the development of distant metastasis. J Surg Oncol 2011; 104 (7): 771-5.
  • Pedersen CB. The Danish Civil Registration system. Scand J Public Health (7 Suppl) 2011; 39: 22-5.
  • Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996; 14 (5): 1679-89.
  • Rougraff BT, Davis K, Lawrence J. Does length of symptoms before diagnosis of sarcoma affect patient survival? Clin Orthop 2007; (462): 181-9.
  • Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: A bad idea. Stat Med 2006; 25 (1): 127-41.
  • Rydholm A, Gustafson P. Should tumor depth be included in prognostication of soft tissue sarcoma? BMC Cancer 2003; 3 (1): 17-21.
  • Saithna A, Pynsent PB, Grimer RJ. Retrospective analysis of the impact of symptom duration on prognosis in soft tissue sarcoma. Int Orthop 2008; 32 (3): 381-4.
  • Shrier I, Platt RW. Reducing bias through directed acyclic graphs. BMC Med Res Methodol 2008; 8: 70-84.
  • Smith PL. Splines as a useful and convenient statistical tool. Am Stat 1979; 33 (2): 57-62.
  • Stojadinovic A, Leung DH, Hoos A, Jaques DP, Lewis JJ, Brennan MF. Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann Surg 2002; 235 (3): 424-34.
  • Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, de Mascarel A, Goussot JF, David M, Bonichon F, Lagarde C. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984; 33 (1): 37-42.
  • Urakawa H, Tsukushi S, Arai E, Kozawa E, Futamura N, Ishiguro N, Nishida Y. Association of short duration from initial symptoms to specialist consultation with poor survival in soft-tissue sarcomas. Am J Clin Oncol 2013; [Epub ahead of print]
  • Vraa S, Keller J, Nielsen OS, Sneppen O, Jurik AG, Jensen OM. Prognostic factors in soft tissue sarcomas: The aarhus experience. Eur J Cancer 1998; 34 (12): 1876-82.
  • Weitz J, Antonescu CR, Brennan MF. Localized extremity soft tissue sarcoma: Improved knowledge with unchanged survival over time. J Clin Oncol 2003; 21 (14): 2719-25.
  • Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS, Evans HL. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: An analysis of 1225 patients. Cancer 2003; 97 (10): 2530-43.